The "Global TROP2 Antibody Market & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. In what marks a significant leap forward in precision oncology, the TROP2 ...
OS Therapies, Inc., a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced that it received a Notice of Allowance from the United ...
By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication.
PITTSBURGH, PA, USA I February 20, 2025 I Myris Therapeutics™ emerged from stealth today to announce its strategic focus. Myris, formerly known as ...
CD Bioparticles announces the launch of its new line of Cellulose Nanoparticles. NEW YORK, NY, UNITED STATES, February 21, 2025 /EINPresswire ...
News Medical on MSN1h
New computational tool iDOMO improves prediction of drug synergyResearchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...
Mexican action thriller Counterstrike is headed to Netflix in February 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback